12:00 AM
 | 
Feb 18, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cadila Pharmaceuticals, Pergamum deal

The companies partnered to develop and commercialize an undisclosed therapeutic peptide to treat infectious diseases. Development of the compound will be...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >